Dolby Laboratories, Inc.
NYSE:DLBInformation Technology Services
-$0.10 today
- Market cap
- $5.32B
- Beta
- 0.80
- P/E (TTM)
- 20.0
- EPS (TTM)
- $2.56
- Dividend yield
- 2.76%
Volume 2.61M
Average 0.73M
DLB Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Dolby Laboratories, Inc.NYSE: DLB
Net Receivables · Q4 FY2026 · quarter ended Sep 2026
Net receivables falls 41.2% from a year ago
Net receivables stood at $301.08M at the end of Q4 FY2026, down 41.2% from a year earlier and down 38.8% from the prior quarter. Over 3 fiscal years it compounded at -12.2% a year.
Context
- Net receivables amounted to 9.5% of total assets at the end of Q4 FY2026, down 6.4 pp from a year earlier.
- Net receivables increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -41.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2026
- 301.08M USD
- Year-over-year change
- -41.2%
- 4-year CAGR
- -8.0%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2026 | 2026-09-25 | 301.08M | -41.2% |
| FY2025 | 2025-09-26 | 511.9M | -0.2% |
| FY2024 | 2024-09-27 | 512.94M | +15.4% |
| FY2023 | 2023-09-29 | 444.38M | +5.9% |
| FY2022 | 2022-09-30 | 419.69M | — |
Net Receivables vs competitors
How DLB compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -41.2% is the lowest of 11, against a peer median of +17.7%.
- Net receivables amounts to 9.5% of total assets for DLB, versus a peer median of 10.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
INGMIngram Micro Holding Corporation | Jun 2026 | $10.68B USD | +16.7% | +6.3% | 49.6% |
| Jun 2026 | CN¥3.15B CNY | -1.0% | +8.0% | 3.7% | |
| Sep 2026 | $1.62B USD | +22.9% | +8.3% | 28.8% | |
| Jun 2026 | $1.25B USD | -2.3% | -5.1% | 10.4% | |
| Jun 2026 | $809M USD | +117.1% | +55.6% | 9.3% | |
| Jun 2026 | $434.36M USD | +9.5% | +12.4% | 24.9% | |
| Sep 2026 | $384.48M USD | +47.8% | +3.7% | 10.1% | |
| Sep 2026 | $301.08M USD | -41.2% | -12.2% | 9.5% | |
| Jun 2026 | $253.97M USD | +18.6% | +13.5% | 9.9% | |
| Jun 2026 | $185.88M USD | +29.5% | +18.1% | 3.2% | |
| Jun 2026 | $126.2M USD | -14.2% | +9.0% | 6.7% | |
| Peer median (excluding DLB) | — | +17.7% | +8.7% | 10.0% | |
Competitors are the stored peer set for DLB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 | FY2026 Sep 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 628.37M | 817.97M | 577.75M | 701.89M | 622.88M |
| Short-term Investments | 189.21M | 139.15M | 0 | 703K | 500K |
| Net Receivables | 419.69M | 444.38M | 512.94M | 511.9M | 301.08M |
| Inventory | 23.55M | 35.62M | 33.73M | 30.42M | 28.45M |
| Other Current Assets | 23.22M | 26.26M | 40.25M | 115.34M | 376.29M |
| Total Current Assets | 1.31B | 1.49B | 1.19B | 1.39B | 1.33B |
| Property, Plant & Equipment (Net) | 560.01M | 521.78M | 518.16M | 503.81M | 498.13M |
| Goodwill | 365.15M | 408.41M | 533.21M | 529.9M | 918.47M |
| Intangible Assets | 112.27M | 167.43M | 434.51M | 397.06M | 389.41M |
| Long-term Investments | 102.51M | 97.81M | 89.27M | 80.21M | 89.44M |
| Tax Assets | 196.19M | 216.66M | 240.44M | 214.36M | 0 |
| Other Non-current Assets | 55.15M | 94.67M | 120.61M | 114.16M | 333.28M |
| Total Non-current Assets | 1.39B | 1.51B | 1.94B | 1.84B | 1.84B |
| Total Assets | 2.7B | 2.99B | 3.13B | 3.23B | 3.17B |
| Account Payables | 14.17M | 20.93M | 17.38M | 17.84M | 19.78M |
| Short-term Debt | 13.26M | 13.63M | 12.24M | 0 | 10.18M |
| Tax Payables | 1.27M | 4.77M | 9.05M | 8.93M | 0 |
| Deferred Revenue | 18.59M | 31.51M | 31.64M | 31.38M | 28.36M |
| Other Current Liabilities | 146.13M | 232.67M | 250.35M | 106.58M | 0 |
| Total Current Liabilities | 277.52M | 422.23M | 417.84M | 437.79M | 417.81M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 12.63M | 14.8M | 20.69M | 0 | 0 |
| Deferred Revenue (Non-current) | 23.2M | 40M | 34.59M | 29.69M | 22.26M |
| Other Non-current Liabilities | 100.12M | 108.34M | 135.85M | 99.84M | 80.31M |
| Total Non-current Liabilities | 173.64M | 200.15M | 225.88M | 158.02M | 138.2M |
| Total Liabilities | 451.15M | 622.38M | 643.72M | 595.81M | 556.01M |
| Common Stock | 94K | 94K | 94K | 94K | 91K |
| Retained Earnings | 2.3B | 2.39B | 2.5B | 2.63B | 2.62B |
| Accumulated OCI | (51.64M) | (36.98M) | (19.19M) | (12.52M) | (12.64M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 2.61B |
| Minority Interest | 4.84M | 17.08M | 9.73M | 9.39M | 8.91M |
| Total Equity | 2.25B | 2.37B | 2.49B | 2.63B | 2.61B |
| Total Debt | 50.94M | 50.65M | 46.99M | 38.88M | 45.8M |
| Net Debt | (577.43M) | (767.32M) | (530.76M) | (663.02M) | (577.08M) |
Dolby Laboratories, Inc.
NYSE:DLB
Intrinsic Alpha fair value
Locked
Current Price
$56.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.